Association of Ki-67 Expression with Clinicopathological Parameters and Prognostic Significance in Breast Cancer at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia, Cross Sectional Analytic Study.
No Thumbnail Available
Date
2026
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Addis Ababa Uinverstiy
Abstract
Background: Breast cancer is the most frequently diagnosed and is one of the leading cause of
cancer related deaths among women worldwide, including Ethiopia. One of the major prognostic
factors is the degree of tumor cell proliferation, and Ki-67, a nuclear protein associated with
cellular proliferation has attracted much attention for its potential use in delineating therapeutic
strategies as well as in outcome prediction. In areas where resources are scarce and gene assays
are mostly inaccessible, markers such as Ki-67 that are regulated are of utmost importance for
the proper stratification of patients.
Objective: To evaluate the prognostic significance of Ki-67 expression in patients with breast
cancer and its association with clinicopathological parameters and one-year outcomes at Tikur
Anbessa Specialized Hospital (TASH), Addis Ababa, Ethiopia.
Methods: An institutional-based retrospective chart review was performed for 130 patients with
histologically confirmed breast cancer and immunohistochemistry (IHC) results at Pathology
department, Tikur Anbessa Specialized Hospital (TASH), Addis Ababa, Ethiopia. Data on
sociodemographic characteristics, tumor grade, stage, lymph node status, and IHC markers (ER,
PR, HER2, and Ki, 67) were collected. KI-67 expression was divided into low (<14%) or high
(14%) levels. Data analysis was done using SPSS version 27. Bivariate and multivariate logistic
regression were used to identify factors independently associated with high KI-67 expression and
its association with one-year clinical outcomes.
Results: The study found that 60.8% of patients showed high Ki-67 expression which reached or
exceeded the 14% threshold. The analysis found that high Ki-67 levels were significantly
associated with ER/PR negativity, HER2 positivity, increased tumor grade, advanced pathologic
stage, lymph node spreading and aggressive molecular subtype patterns. The multivariate
analysis identified HER2 positive status with AOR = 11.35 and 95% CI = 3.02-42.73 and p <
0.001 and lymph node involvement with AOR = 5.85 and 95% CI = 1.70-20.17 and p = 0.005
and molecular subtype with AOR = 4.98 and 95% CI = 2.41-10.30 and p < 0.001 as independent
factors that linked to high Ki-67 expression. During the one year follow-up, patients with a high
proliferation index of the Ki-67 tumor cell marker had higher rates of cancer recurrence, disease
progression, and mortality.
Conclusion: High Ki-67 expression is very common in breast cancer patients in Ethiopia and its
independent association has been found between the aggressive tumor features and poor short term outcomes. This study strongly advocates for the standard inclusion of Ki-67 in pathology
reports for the betterment of the prognostic evaluation and direction of therapy decisions,
especially in areas where the access to molecular profiling is very limited.
Description
Keywords
: Ki-67, Breast Cancer, Clinicopathological Parameters, Prognosis, Ethiopia, Tikur Anbessa Specialized Hospital.